IFNA2, interferon alpha 2, 3440

N. diseases: 355; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.330 AlteredExpression disease BEFREE Serum concentrations of IFN-alpha 2 were increased, while serum levels of IFN-gamma were decreased confronted with those of controls; the severity of IMTG, revealed at US as Heckmatt scores, was inversely predicted by IFN-alpha 2 serum concentrations; IMTG scores were not predicted by serum levels of IFN-gamma; IMTG scores were predicted by HS severity, ascertained at US; HS severity was predicted by visceral adipose tissue, assessed by US, but the latter was not instrumental to IMTG. 30602382 2019
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.330 GeneticVariation disease BEFREE Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR. 22497814 2012
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.330 Biomarker disease BEFREE Only HCV genotype was independently associated with a sustained virological response (SVR) to interferon alpha-2b and ribavirin treatment after adjusting for age, alcohol use, steatosis, BMI, stage III-IV fibrosis, serum AFP, and HCV load. 17226072 2007
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.330 Biomarker disease CTD_human Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. 7736406 1995